Kow, C. S., & Hasan, S. S. (2020). Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease. Rheumatol Int.
استشهاد بنمط شيكاغوKow, Chia Siang, و Syed Shahzad Hasan. "Use of Rituximab and the Risk of Adverse Clinical Outcomes in COVID-19 Patients With Systemic Rheumatic Disease." Rheumatol Int 2020.
MLA استشهادKow, Chia Siang, و Syed Shahzad Hasan. "Use of Rituximab and the Risk of Adverse Clinical Outcomes in COVID-19 Patients With Systemic Rheumatic Disease." Rheumatol Int 2020.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.